Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) Current Taxes (2012)

Updated

Chemomab Therapeutics' Current Taxes came in at $5.27 million for Q3 2019, up 180.0% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Current Taxes (2012) Analysis & Trends

At the end of FY2018, Chemomab Therapeutics' Current Taxes was $3.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,138.33 Bn 1,106.91 Bn 19.71 Bn -
2 Johnson & Johnson 618.82 Bn 537.35 Bn 17.26 Bn 1.05 Bn
3 AbbVie 503.36 Bn 476.47 Bn 12.70 Bn -
4 Merck 369.59 Bn 323.96 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 298.57 Bn 262.56 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.25 Bn 234.94 Bn 12.86 Bn 1.47 Bn
7 Amgen 237.35 Bn 192.75 Bn 7.24 Bn -
8 Gilead Sciences 191.27 Bn 165.47 Bn 6.22 Bn -
9 Pfizer 170.03 Bn 116.68 Bn 10.94 Bn 653.00 Mn
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 150,599.98
API Access

Chemomab Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=CMMB&period=max&api_key=YOUR_API_KEY